Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Dabigatran 💬
(Dabigatran (USAN/INN))		[1] Dabigatran (Dabigatran)[1] Dabigatran[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[3] 85, 91, 124 💬
2 Dabigatran etexilate 💬
(Dabigatran etexilate (USAN/INN))		[1] Dabigatran etexilate (Dabigatran etexilate)[1] Dabigatran etexilate[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[2] 51, 75 💬
3 Dabigatran etexilate mesylate 💬
(Dabigatran etexilate mesylate (USAN), Dabigatran etexilate methanesulfonate (JAN), Dabigatran etexilate mesilate, DABIGATRAN, DABIGATRAN ETEXILATE)		[1] Dabigatran etexilate (Dabigatran etexilate)[1] Dabigatran etexilate[1] F2 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬[2] 51, 75 💬